Immune-mediated vincristine-induced neuropathy: Unlocking therapies

被引:0
作者
Savelieff, Masha G. [1 ]
Feldman, Eva L. [1 ,2 ]
机构
[1] Univ Michigan, NeuroNetwork Emerging Therapies, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1084/jem.20210286
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vincristine-induced peripheral neuropathy (VIPN) is a prevalent and painful complication in cancer patients that lacks effective treatments. In this issue of JEM, Starobova et al. (2021. J. Exp. Med. https://doi.org/10.1084/jem.20201452) report that VIPN is driven by innate immune system activation, a discovery that unlocks immunotherapies as potential treatments.
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Pharmacogenomics of Vincristine-Induced Peripheral Neuropathy Implicates Pharmacokinetic and Inherited Neuropathy Genes
    Wright, Galen E. B.
    Amstutz, Ursula
    Drogemoller, Britt, I
    Shih, Joanne
    Rassekh, Shahrad R.
    Hayden, Michael R.
    Carleton, Bruce C.
    Ross, Colin J. D.
    Carleton, Bruce
    Ross, Colin
    Rassekh, Shahrad
    Visscher, Henk
    Aminkeng, Folefac
    Wright, Galen
    Drogemoller, Britt
    Higginson, Michelle
    Massah, Nasim
    Miao, Fudan
    Bhavsar, Amit
    Lee, Jong
    Bendyshe-Walton, Tessa
    Tanoshima, Reo
    Johnson, David
    Zhuwaki, Carnation
    Honcharik, Nick
    Jong, Geert't
    Israels, Sara
    Staub, Michelle
    Rieder, Michael
    Faught, Lauren
    Ito, Shinya
    Nathan, Paul
    Karande, Smita
    Vaillancourt, Regis
    Johnston, Donna
    Nguyen, Kimmy
    Bussieres, Jean-Francois
    Lebel, Denis
    Jean-Louis, Jennifer
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (02) : 402 - 410
  • [42] A new animal model of vincristine-induced nociceptive peripheral neuropathy
    Authier, N
    Gillet, JP
    Fialip, J
    Eschalier, A
    Coudore, F
    NEUROTOXICOLOGY, 2003, 24 (06) : 797 - 805
  • [43] VINCRISTINE-INDUCED NEUROPATHY - A CLINICAL STUDY OF 50 LEUKEMIC PATIENTS
    SANDLER, SG
    TOBIN, W
    HENDERSON, ES
    NEUROLOGY, 1969, 19 (04) : 367 - +
  • [44] Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer
    Stephen Sands
    Elena J. Ladas
    Kara M. Kelly
    Michael Weiner
    Meiko Lin
    Deborah Hughes Ndao
    Amie Dave
    Linda T. Vahdat
    Julia Glade Bender
    Supportive Care in Cancer, 2017, 25 : 701 - 708
  • [46] Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
    Madsen, Marie Lindhard
    Due, Hanne
    Ejskjaer, Niels
    Jensen, Paw
    Madsen, Jakob
    Dybkaer, Karen
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (03) : 471 - 485
  • [47] GANGLIOSIDE TREATMENT REDUCES ELECTROPHYSIOLOGIC ALTERATIONS IN VINCRISTINE-INDUCED NEUROPATHY
    DIGREGORIO, F
    FAVARO, G
    FIORI, MG
    PERIPHERAL NERVE DEVELOPMENT AND REGENERATION: RECENT ADVANCES AND CLINICAL APPLICATIONS, 1989, 19 : 141 - 144
  • [48] Vincristine-induced peripheral neuropathy in children with cancer: A systematic review
    van de Velde, Mirjam E.
    Kaspers, Gertjan L.
    Abbink, Floor C. H.
    Wilhelm, Abraham J.
    Ket, Johannes C. F.
    van den Berg, Marleen H.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 114 : 114 - 130
  • [49] Evidence for an antihyperalgesic effect of venlafaxine in vincristine-induced neuropathy in rat
    Marchand, F
    Alloui, A
    Pelissier, T
    Hernández, A
    Authier, N
    Alvarez, P
    Eschalier, A
    Ardid, D
    BRAIN RESEARCH, 2003, 980 (01) : 117 - 120
  • [50] Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review
    Marie Lindhard Madsen
    Hanne Due
    Niels Ejskjær
    Paw Jensen
    Jakob Madsen
    Karen Dybkær
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 471 - 485